Skip to main content

Avalyn Pharma Inc.

AVLN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001540171

In the last 90 days, Avalyn Pharma Inc. insiders filed 0 open-market purchases and 5 sales; 115 institutions reported holding it in 13F filings for Q3 2026, worth $1.32B in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Avalyn Pharma Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Avalyn Pharma Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 12, 202610-Q–Sep 30, 2026SECIndex
Nov 12, 20268-K2.029.01Nov 12, 2026SECIndex
Sep 16, 20268-K5.02Sep 15, 2026SECIndex
Aug 12, 202610-Q–Jun 30, 2026SECIndex
Aug 12, 20268-K2.029.01Aug 12, 2026SECIndex
Jul 1, 20268-K1.019.01Jun 29, 2026SECIndex
Jun 17, 20268-K7.01Jun 17, 2026SECIndex
Jun 3, 202610-Q–Mar 31, 2026SECIndex
Jun 3, 20268-K2.029.01Jun 3, 2026SECIndex
May 1, 20268-K5.039.01May 1, 2026SECIndex